A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo.

Indeed, in both AMO-1 and MOLP-8 cells, highly significant inhibition of constitutive Akt phosphorylation ( P <0.001 compared with vehicle-treated controls) was observed at concentrations of as low as 10 nM ( Figure 3a ).

also in 132,142 other papers